The data may be found in the EMBL database, the INSDC databases (Assembly_name: KPLM21; Study_ID: PRJEB7075; Sample_ID: ERS537769 \| Contigs: CCVM01000001-CCVM01000154).

Introduction {#sec001}
============

Bacterial adhesion to epithelial cells and abiotic surfaces is frequently mediated by diverse surface proteinaceous appendages referred to as adhesins. Gram-negative bacteria develop several fimbrial adhesins that are proteinaceous non-flagellar filaments with thin hair-like extension on the bacterial cell surface \[[@pone.0116215.ref001]\]. They are assembled by dedicated secretion systems and are composed primarily of the major repeating subunit protein with minor-subunit proteins including the adhesion subunits that enable the bacteria to specifically target a cell component or a surface \[[@pone.0116215.ref002]\]. Studies on the biochemistry and genetics of fimbrial biosynthesis have given rise to a nomenclature that distinguishes between fimbriae on the basis of their assembly mechanism \[[@pone.0116215.ref003]\]. The chaperone/usher (CU)-dependent pathway represents the most abundant secretory pathway among Gram-negative bacteria \[[@pone.0116215.ref003]\]. It is composed of a chaperone periplasmic protein and an outer membrane protein named the usher. The chaperone prevents self-aggregation of the fimbriae subunits and directs them to the usher, which in turn is involved in the secretion and correct assembly of the external fimbrial subunits \[[@pone.0116215.ref003]\]. Genes encoding the CU pathway are located on both chromosomal and plasmid molecules and are clustered with similar organization among different bacteria: an upstream region containing regulatory genes and a single downstream operon containing the required structural and assembly components. In addition, multiple CU pathways may be present in a single bacterial genome, which presumably confers the ability to adhere to a variety of different receptors and surfaces \[[@pone.0116215.ref004]--[@pone.0116215.ref006]\]. Expression of the CU gene clusters is typically highly regulated, subject to phase variation and responsive to environmental cues \[[@pone.0116215.ref007]\]. This cross-talk probably ensures that each bacterium does not express all pilus types at a given time, enabling the control of adhesive specificity.

The CU family has been described among members of the beta-proteobacteria and in cyanobacteria \[[@pone.0116215.ref003],[@pone.0116215.ref008]\], but is mostly prevalent among enteric members of the γ-proteobacteria, including *Escherichia coli*, *Salmonella* and *Yersinia*. *Klebsiella pneumoniae* is a pathogenic *Enterobacteriaceae* that commonly causes nosocomial, increasingly multidrug resistant infections and is also emerging as a community pathogen \[[@pone.0116215.ref002],[@pone.0116215.ref009],[@pone.0116215.ref010]\]. Two classical CU fimbriae have been described in *Klebsiella*, type 1 and type 3-pili. By binding to mannosylated glycoproteins, type 1 pili allow bacterial adhesion to uroepithelial cells and the development of cystitis \[[@pone.0116215.ref011]--[@pone.0116215.ref013]\]. Type 3 fimbriae mediate adhesion to several cell types *in vitro* such as tracheal epithelial cells, renal tubular cells, extracellular matrix proteins and the membrane of human lung tissue \[[@pone.0116215.ref014]--[@pone.0116215.ref016]\]. In addition, both fimbriae have been associated with biofilm formation in *K*. *pneumoniae* \[[@pone.0116215.ref002],[@pone.0116215.ref017]\]. Recently Wu et al. \[[@pone.0116215.ref018]\] described nine fimbrial loci found in *K*. *pneumoniae* NTUH- K2044: *fim*, *mrk*, and seven other fimbrial loci called *kpa* to *kpg*. Apart from the NTUH-K2044 *kpc* locus, no studies have investigated the *in vitro* and/or *in vivo* role of the other *K*. *pneumoniae* accessory fimbrial potential operons \[[@pone.0116215.ref018]\].

Given the recent increase in *K*. *pneumoniae* clinical importance and its well recognized diversity of niches, we assessed the presence of CU-like genes in this pathogen by searching for genes encoding putative fimbrial usher proteins. We analyzed their distribution, genetic conservation and genetic location. We used a reverse genetics approach to further investigate adhesion and colonization phenotype associated with eight LM21 usher operon candidates and *in vitro* and *in vivo* models.

Material and Methods {#sec002}
====================

Identification of Chaperone-Usher loci in *K*. *pneumoniae* LM21 {#sec003}
----------------------------------------------------------------

*K*. *pneumoniae LM21* was isolated from a cutaneous wound of a patient hospitalized in a intensive care unit of the teaching hospital of Clermont-Ferrand. Its sequencing was performed by GATC Biotech (Konstanz, Germany) using Illumina technology and a 2×100 nucleotide (nt) paired-end strategy. All reads were pre-processed to remove low quality or artefactual nucleotides. First, all nucleotides occurring at 5\' and 3\' ends and supported by a Phred quality score \< 30 were trimmed off using Sickle (<http://www.github.com/najoshi/sickle>). Second, contaminant oligonucleotides (i.e. library adaptors) were detected and trimmed off using AlienTrimmer \[[@pone.0116215.ref019]\]. Third, reads shorter than 60 nt after the above cleaning steps were discarded, as well as those containing more than 20% nucleotides with Phred score \< 30. Resulting reads were assembled using clc_assembler from the CLC Genomics Workbench analysis package (<http://www.clcbio.com/products/clc-genomics-workbench/>). Contigs were reordered and reoriented, using as reference the genomic sequence of strain MGH 78578, with Mauve Contig Mover \[[@pone.0116215.ref020]\]. Obvious contaminant contigs were discarded. 154 remaining contigs (total genome size: 5,509,751 nt; N50, 104,592 nt) were subsequently imported into the Microscope database system \[[@pone.0116215.ref021]\]. The genome was annotated automatically within the MicroScope platform and manually visualized using the Magnifying Genomes (MaGe) web interface \[[@pone.0116215.ref022],[@pone.0116215.ref023]\]. The LM21 genome sequence was deposited in the EMBL database and is available from the INSDC databases (Assembly_name: KPLM21; Study_ID: PRJEB7075; Sample_ID: ERS537769 \| Contigs: CCVM01000001-CCVM01000154).

The NCBI Blast 2.28+ program was used to look for the presence of usher-like sequences in *K*. *pneumoniae* strain LM21. Usher amino acid sequences annotated in NCBI were used as initial BLASTp queries to look for the presence of CU in *K*. *pneumoniae* LM21. BLASTp searches were performed using the BLOSUM62 matrix and an E-value cut-off score of 0.1. Newly identified proteins with a reported E-value of 0 were retained, whereas hits with an E-value \>0 were screened for the presence of an usher protein family domain (PFAM00577) and/or flanking chaperone (PF00345, PF02753 or COG3121) for encoding genes before they were added to the usher query list. The NCBI Conserved Domain Database (CDD) component of the NCBI Entrez query retrieval system was used to examine amino-acid sequences for conserved domain \[[@pone.0116215.ref024]\].

After each BLASTp run, the updated usher query database was used to re-probe the genome sequences until no new sequences were found. All putative usher amino-acid sequences encoded by LM21 *K*. *pneumoniae* genome were downloaded from MaGe database. They are listed in [S1 Table](#pone.0116215.s001){ref-type="supplementary-material"}. The presence of the eight usher encoded genes predicted by *in silico* analysis was verified by PCRs using primers listed in [Table 1](#pone.0116215.t001){ref-type="table"} (P1 to P16).

10.1371/journal.pone.0116215.t001

###### Primers used in this study.

![](pone.0116215.t001){#pone.0116215.t001g}

  *Num*   *Primers Name*           Oligonucleotide sequence (5\'- 3\')                                                          PCR product size (bp)   Use
  ------- ------------------------ -------------------------------------------------------------------------------------------- ----------------------- ------------------------------------------------------------------------------------------------------
  P1      LM21\_*kpaC*-Fw          CCGGGCACCTATCACCTG                                                                           607 pb                  Primers used to check the presence of usher LM21*kpaC*
  P2      LM21\_*kpaC*-Rv          GCTTAACCGGCACGCTGG                                                                                                   
  P3      LM21\_*kpbC*-Fw          GTCCTGGCGAGTTCGTTACGG                                                                        658 pb                  Primers used to check the presence of usher LM21*kpbC*
  P4      LM21\_*kpbC*-Rv          CGTTGGCGCCGTAGTCGATACG                                                                                               
  P5      LM21\_*kpd*C-Fw          GAGATCGCCTGCAGCGGCAG                                                                         568 pb                  Primers used to check the presence of usher LM21*kpdC*
  P6      LM21\_*kpdC*-Rv          CAGCGCTGTCCACCGTCGC                                                                                                  
  P7      LM21\_*kpeC*-Fw          CCGCCAACAGCGATGATAAGCC                                                                       509 pb                  Primers used to check the presence of usher LM21*kpeC*
  P8      LM21\_*kpeC*-Rv          GAACCCGCGCATCAGCGAC                                                                                                  
  P9      LM21\_*kpgC*-Fw          GGTATTGACCGGCAGCGTG                                                                          574 pb                  Primers used to check the presence of usher LM21*kpgC*
  P10     LM21\_*kpgC*-Rv          GCGGGCAAAGCATCGACG                                                                                                   
  P11     LM21\_*kpj*C-Fw          TCTCTTTGCGAAGCCAAC                                                                           582 pb                  Primers used to check the presence of usher LM21*kpjC*
  P12     LM21\_*kpj*C-Rv          CATGGATCGGGAATGGAT                                                                                                   
  P13     LM21\_*mrkC*-Fw          GCCGCAAAGCGGTTGGTG                                                                           592 pb                  Primers used to check the presence of usher LM21*mrkC*
  P14     LM21\_*mrkC-*Rv          CGACGCCGTTCTACATTACC                                                                                                 
  P15     LM21\_*fimC*-Fw          GCTGACCCCGTAATAGAG                                                                           475 pb                  Primers used to check the presence of usher LM21*fimC*
  P16     LM21\_*fimC*-Rv          CGCGCCACCCTCTATCTC                                                                                                   
  P17     LM21\_*kpa-Kana-*Fw      AGCCATGACGCAGGCGCGACTGCTTCTCCCTGCCTGTCCGCGGAGTATCTGAATTCATGGGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*kpa* isogenic mutant construction
  P18     LM21\_*kpa-Kana-*Rv      CATATCAGCCCCTCTTCCATGTTGAAAACCTGCATCCATTACCGACATTCGGCCTGATAGCATATGAATATCCTCCTTAGTTC                                  
  P19     LM21\_*kpb-Kana*-Fw      AGCATAGTAGGGATAAAAAAAGAAGTATTTTTCTCATTCTTTATTGTTCCTTGGTCAATAGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*kpb* isogenic mutant construction
  P20     LM21\_*kpb-Kana-Rv*      GATGTGTCTATGCCAAATAAGAATAATGGATTATTCAAACTATCCACCATCTTCTTTGCACATATGAATATCCTCCTTAGTTC                                  
  P21     LM21\_*kpd-Kana-*Fw      TCAGGGGTACCTCTTCTGCTGGCCGGCGGGTACTGCGCTTCGCTGTCGGCAGCGTGCCAGGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*kpd* isogenic mutant construction
  P22     LM21\_*kpd-Kana-*Rv      ACAGGAAGTTGATGTTTCCTTTACTGGCGCATGCCTGACGGCGCTGTGCCGCCAGGCAGACATATGAATATCCTCCTTAGTTC                                  
  P23     LM21\_*kpe-Kana-*Fw      GCGTCAGGGCGACCCGACGCAGGAGAGTTAAAAAGGACATGATAACGTCTGCTGTAAGATGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*kpe* isogenic mutant construction
  P24     LM21\_*kpe-Kana-*Rv      TTTGGCGCTGTGCAGACGTTTAGCGCCCCCGTTTCGGCGCACTAAGCGTCTGATGTCGCGCATATGAATATCCTCCTTAGTTC                                  
  P25     LM21\_*kpg-Kana-*Fw      GCGCTCAGCCCCAGCAGAAAGAGGAAAGGAAGTAGACGAAAAACAGATTTCATAGCCGCCGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*kpg* isogenic mutant construction
  P26     LM21\_*kpg-Kana-*Rv      AGAATAACAACAGCCAGGGTGCGGGAGTATGCCTTGTTGCCCGTTACCGCCGGGCGGGCGCATATGAATATCCTCCTTAGTTC                                  
  P27     LM21\_*kpj-Kana*-Fw      ATTAATGGGTATGGAATTTTGGGTCAGTTCAATTTCAATATGAAATATGCATGCCTCTTGGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*kpj* isogenic mutant construction
  P28     LM21\_*kpj-Kana-*Rv      ACCACTTCATTTTATTCTTCCTCGTAAGGACGGCTATTTACTTTGCTCAAGGGCGCAGAGCATATGAATATCCTCCTTAGTTC                                  
  P29     LM21\_*mrk-Kana-*Fw      ATTAAGACGATAAAAAGCGTTAGTAATTTCCTCAGCGACATACGCTATCCTTTGTTGTTTGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*mrk* isogenic mutant construction
  P30     LM21\_*mrk-Kana-*Rv      CATTAATGACTATGGCGCCGATGTCGCAGTGAAAGTGGCCGTTAAATAAGGGAAAAGCTACATATGAATATCCTCCTTAGTTC                                  
  P31     LM21\_*fim-Kana-*Fw      GGGACACGCTGCGCATGACCAGAAGCAATGACAGCCGGGCAACGTCGGACCGGAGGGATAGTAGGCTGGAGCTGCTTCG              1595 pb                 LM21Δ*fim* isogenic mutant construction
  P32     LM21\_*fim-Kana-*Rv      GGTGCGCCCAGGGTGAACAGGGCGCCCAGCAGATACTGCAGTGTTCTCATCATGATCTCC[CATATGAATATCCTCCTTAGTTC]{.ul}                           
  P33     *kana-*Fw                GTAGGCTGGAGCTGCTTCG                                                                          1475 pb                 Primers used to check the presence of kanamycin cassette
  P34     *kana-*Rv                CATATGAATATCCTCCTTAGTTC                                                                                              
  P35     LM21\_*kpa*-Fw           GTACGCCAACGTCTTCCGC                                                                          2451 pb                 Two-step PCR amplification to generate fragment containing *kpa* operon promoter fused to LM21*kpaC*
  P36     LM21_P\_*kpa*-Rv         TTCCCTGACATACCATAATCATCCTGGCCGCGTTCGATAC                                                                             
  P37     LM21_P\_*kpa-*Fw         GTATCGAACGCGGCCAGGATGATTATGGTATGTCAGGGAA                                                                             
  P38     LM21\_*kpa*-Rv           TTACCGACATTCGGCCTG                                                                                                   
  P39     LM21\_*kpb*-Fw           GGTGAAAAAGCATCTGAGC                                                                          2661 bp                 Two-step PCR amplification to generate fragment containing *kpb* operon promoter fused to LM21*kpbC*
  P40     LM21_P\_*kpb*-Rv         CCATTATTCTTATTTGGCATCTACCGGTTTAGCACGACC                                                                              
  P41     LM21_P\_*kpb-*Fw         GGTCGTGCTAAACCGGTAGATGCCAAATAAGAATAATGG                                                                              
  P42     LM21\_*kpb*-Rv           TTAGCGACAAACCGTTTCG                                                                                                  
  P43     LM21\_*kpd*-Fw           GAAAGCGCAGGGAGTATG                                                                           2454 bp                 Two-step PCR amplification to generate fragment containing *kpd* operon promoter fused to LM21*kpdC*
  P44     LM21_P\_*kpd*-Rv         CTTGATCTCCCTGAGTTTCATTCAACATAATGACCTCCTGGC                                                                           
  P45     LM21_P\_*kpd-*Fw         GCCAGGAGGTCATTATGTTGAATGAAACTCAGGGAGATCAAG                                                                           
  P46     LM21\_*kpd*-Rv           TTACTTCTCCTTTATTCCCGG                                                                                                
  P47     LM21\_*kpe*-Fw           CTATGATGAATCCTATGCCG                                                                         2762 bp                 Two-step PCR amplification to generate fragment containing *kpe* operon promoter fused to LM21*kpe*C
  P48     LM21_P\_*kpe*-Rv         CCGGGCCGTGGCGCATGATCGAGCTGCTTTTTCAGC                                                                                 
  P49     LM21_P\_*kpe-*Fw         GCTGAAAAAGCAGCTCGATCATGCGCCACGGCCCGG                                                                                 
  P50     LM21\_*kpe-*Rv           TTAAAAAGGACATGATAACGTC                                                                                               
  P51     LM21\_*kpg*-Fw           CTAATATCCTGCGGAAGG                                                                           2802 pb                 Two-step PCR amplification to generate fragment containing *kpg* operon promoter fused to LM21*kpgC*
  P52     LM21_P\_*kpg*-Rv         CGCCGTCCGGTAAGCTCATTCAGGATTGATAGTGTTGGC                                                                              
  P53     LM21_P\_*kpg-*Fw         GCCAACACTATCAATCCTGAATGAGCTTACCGGACGGCG                                                                              
  P54     LM21\_*kpg*-Rv           TCAGCGTGTCTGGCACAG                                                                                                   
  P55     LM21\_*kpj*-Fw           GCTTTAACTCGCAGAAAGG                                                                          2927pb                  Two-step PCR amplification to generate fragment containing *kpj* operon promoter fused to LM21*kpjC*
  P56     LM21_P\_*kpj*-Rv         AATCCATCGTTGAGGCATTCAGCTGGTCCAGGTGG                                                                                  
  P57     LM21_P\_*kpj*-Fw         CCACCTGGACCAGCTGAATGCCTCAACGATGGATT                                                                                  
  P58     LM21\_*kpj*-Rv           TTAACTTTCATTCTCTTCTCCTGAC                                                                                            
  P59     LM21\_*mrk*-Fw           GCTGACCAACAAAATCATCC                                                                         2794 pb                 Two-step PCR amplification to generate fragment containing *mrk* operon promoter fused to LM21*mrkC*
  P60     LM21_P\_*mrk*-Rv         CAGAATGACCTCTGCTTCATGCTGACCTCAGAATAAAAATACA                                                                          
  P61     LM21_P\_*mrk*-Fw         TGTATTTTTATTCTGAGGTCAGCATGAAGCAGAGGTCATTCTG                                                                          
  P62     LM21\_*mrk*-Rv           GCCATTAAGACGATAAAAAGC                                                                                                
  P63     LM21\_*fim*-Fw           CAAATTTTATGTTAACGACGC                                                                        2893 pb                 Two-step PCR amplification to generate fragment containing *fim* operon promoter fused to LM21*fim*C
  P64     LM21_P\_*fim*-Rv         CCATATTTCCGATGTGACATTCATGCGCGAATATCGTC                                                                               
  P65     LM21_P\_*fim-*Fw         GACGATATTCGCGCATGAATGTCACATCGGAAATATGG                                                                               
  P66     LM21\_*fim*-Rv           GACGTTATCATGTCCTTTTTAA                                                                                               
  P67     LM21-*kpa-*RT-qPCR-Fw    GCTCCGACGATAAAGAATATAAC                                                                      113 pb                  Primers used for qPCR to verify the expression of *kpaC*
  P68     LM21\_*kpa-*RT-qPCR-Rv   CAGGTTGGTGTATTTATCTTCC                                                                                               
  P69     LM21\_*kpb-*RT-qPCR-Fw   GGTAATTATACCTCTCGCTCAC                                                                       114 pb                  Primers used for qPCR to verify the expression of *kpbC*
  P70     LM21\_*kpb-*RT-qPCR-Rv   GTCCCAGTAATCTTCAATCAAC                                                                                               
  P71     LM21\_*kpd-*RT-qPCR-Fw   CTGTCATTTAACGGAATCTGG                                                                        112 pb                  Primers used for qPCR to verify the expression of *kpdC*
  P72     LM21\_*kpd-*RT-qPCR-Rv   GCTGGGCATACAGATAATAATTG                                                                                              
  P73     LM21\_*kpe-*RT-qPCR-Fw   CAATACCATAACCTCTCGGTC                                                                        149 pb                  Primers used for qPCR to verify the expression of *kpeC*
  P74     LM21\_*kpe-*RT-qPCR-Rv   CGATCAAAACCTTTGCTGTAC                                                                                                
  P75     LM21\_*kpg-*RT-qPCR-Fw   GATGTCTGACGATGAAATGC                                                                         125 pb                  Primers used for qPCR to verify the expression of *kpgC*
  P76     LM21\_*kpg-*RT-qPCR-Rv   CAAAGGTCTCGTAGATCACATAC                                                                                              
  P77     LM21\_*kpj-*RT-qPCR-Fw   CTGATATCACGTTTGTTGACG                                                                        121 pb                  Primers used for qPCR to verify the expression of *kpj*C
  P78     LM21\_*kpj-*RT-qPCR-Rv   CGGGAATAAACTTCTCGATC                                                                                                 
  P79     LM21\_*mrk-*RT-qPCR-Fw   CTGTGGTTTGGCGATAAC                                                                           125 pb                  Primers used for qPCR to verify the expression of *mrkC*
  P80     LM21\_*mrk-*RT-qPCR-Rv   CCGTAGTTAAGGTTGTTTTCAC                                                                                               
  P81     LM21\_*fim-*RT-qPCR-Fw   GAAAAACATGGGCTATTTCG                                                                         115 pb                  Primers used for qPCR to verify the expression of *fimC*
  P82     LM21\_*fim-*RT-qPCR-Rv   GGATTTGTTATAGAGAAAACGC                                                                                               
  P83     RT-*gyrA*-Fw             ATTGGGCAATGACTGGAACAA                                                                        149 pb                  Primers used for qPCR to verify the expression of *gyrA* in LM21 wild type
  P84     RT-*gyrA*-Rv             CCACCAGCATGTAACGCAG                                                                                                  

Locus structure prediction and genetic analysis {#sec004}
-----------------------------------------------

To define potential operon genetic organization, we visualized flanking regions of usher nucleotide sequences in xBase2 \[[@pone.0116215.ref025]\]. Fimbrial encoding genes were identified using conserved protein domain searches \[[@pone.0116215.ref024]\] and sequence homology to annotated genes. Intergenic regions \>200pb were investigated for the presence of protein encoding sequences with conserved fimbrial domains or significant sequence identity to fimbrial subunits.

Multiple sequence alignment and phylogenetics {#sec005}
---------------------------------------------

Publicly available *K*. *pneumoniae* genomes used for this study were those from strains HS11286, MGH 78578, NTUH-K2044, 342 (reassigned to *K*. *variicola* since genome sequencing), KCTC 2242, 1084, JM45, CG43, Kp13, 30684/NJST258_2 and 30660/NJST258_1.

Full-length usher amino acid sequences from intact fimbrial operons were used to infer evolutionary relationships. Sequences were aligned in MAFFT v6.617b \[[@pone.0116215.ref026],[@pone.0116215.ref027]\], using iterative global-pair refinement method with default gap penalties. The alignment was cleaned with trimal \[[@pone.0116215.ref028]\] so that every site with more than 30% of gaps or with an average similarity inferior to 0.0001 was removed.

Phylogenetic analyses were performed with PhyML 3.1 \[[@pone.0116215.ref029]\], using LG+gamma model with a 4 categories gamma law. To estimate the confidence in the tree topology, statistical aLRT-SH-like supports were computed \[[@pone.0116215.ref030]\]. Alignments and phylogenetic tree were repeated with usher sequences of previous usher phylograms \[[@pone.0116215.ref003]\] to check tree validity (data not shown).

Bacterial strains, plasmids and growth conditions {#sec006}
-------------------------------------------------

The bacterial strains and plasmids used in the study are shown in [Table 2](#pone.0116215.t002){ref-type="table"}. All bacterial strains were stored at −80°C in Lysogeny Broth (LB) medium containing 20% glycerol. When appropriate, antibiotics were added to the media at the following concentrations: ampicillin (50μg/ml), kanamycin (50μg/ml), tetracycline (20μg/ml), streptomycin (50μg/ml) and spectinomycin (50μg/ml). LB media, 0.4% glucose M63B1 minimal medium (M63B1--0.4% Glu) and Dulbecco's modified Eagle's medium (DMEM) were used for experiments. Bacterial growth was monitored by measuring the optical density at 620 nm (OD~620~) and plating dilution on agar plates to determine colony forming units.

10.1371/journal.pone.0116215.t002

###### Strains and plasmids used.

![](pone.0116215.t002){#pone.0116215.t002g}

  Num            Strains or Plasmids                       Decription                                                                                                                                            Source and/or reference
  -------------- ----------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------
  S1             LM21 *gfp*                                LM21 strain SHV-1::*aadA7*-*gfp*mut3; serogroup O25, K35, Sp^r^                                                                                       \[[@pone.0116215.ref064]\]
  S2             LM21 *gfp*/pSTAB                          LM21 gfp/pSTAB; Sp^r^, Ap^r^                                                                                                                          This study
  S3             LM21 *gfp*-*Strepto*/pSTAB                LM21 *gfp*/pSTAB; Sp^r^, Ap^r^, St^r^                                                                                                                 This study
  S4             LM21Δ*kpaC*-*kana*                        LM21 *gfp* Δ*kpaC*::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S5             LM21Δ*kpbC*-*kana*                        LM21 *gfp* Δ*kpbC*::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S6             LM21Δ*kpdC*-*kana*                        LM21 *gfp* Δ*kpdC*::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S7             LM21Δ*kpeC-kana*                          LM21 *gfp* Δ*kpeC*::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S8             LM21Δk*pgC*-*kana*                        LM21 *gfp* Δ*kpgC*::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S9             LM21Δ*kpjC*-*kana*                        LM21 *gfp* Δ*kpjC*::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S10            LM21Δ*mrkC*-*kana*                        LM21 *gfp* Δ*mrk*C::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S11            LM21Δ*fimC*-*kana*                        LM21 *gfp* Δ*fim*C::KmFRT; Sp^r^, Km^r^                                                                                                               This study
  S12            LM21Δ*kpaC-kana*/pSTAB-*kpaC*             LM21 *gfp* Δ*kpa*C::KmFRT/pSTAB\_*kpaC*; Sp^r^, Ap^r^, Km^r^                                                                                          This study
  S13            LM21Δ*kpbC-kana*/pSTAB-*kpbC*             LM21 *gfp* Δ*kpbC*::KmFRT/pSTAB\_*kpbC*; Sp^r^, Ap^r^, Km^r^                                                                                          This study
  S14            LM21Δ*kpdC-kana*/pSTAB-*kpdC*             LM21 *gfp* Δ*kpd*C::KmFRT/pSTAB\_*kpdC*; Sp^r,^ Ap^r^, Km^r^                                                                                          This study
  S15            LM21Δ*kpeC-kana*/pSTAB-*kpeC*             LM21 *gfp* Δ*kpeC*::KmFRT/pSTAB\_*kpeC;* Sp^r^, Ap^r^, Km^r^                                                                                          This study
  S16            LM21Δ*kpgC-kana*/pSTAB-*kpgC*             LM21 *gfp* Δ*kpgC*::KmFRT/pSTAB\_*kpgC*; Sp^r^, Ap^r^, Km^r^                                                                                          This study
  S17            LM21Δ*kpjC-kana*/pSTAB-*kpjC*             LM21 *gfp* Δ*kpjC*::KmFRT/pSTAB\_*kpjC*; Sp^r^, Ap^r^, Km^r^                                                                                          This study
  S18            LM21Δ*mrkC-kana*/pSTAB-*mrkC*             LM21 *gfp* Δ*mrkC*::KmFRT/pSTAB\_*mrkC*; Sp^r^, Ap^r^, Km^r^                                                                                          This study
  S19            LM21Δ*fimC-kana*/pSTAB-*fim*              LM21 *gfp* Δ*fimC*::KmFRT/ pSTAB\_*fim*C, Sp^r^, Ap^r^, Km^r^                                                                                         This study
  S20            LM21Δ*kpaC-kana/*pSTAB                    LM21 *gfp* Δ*kpaC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S21            LM21Δ*kpbC-kana/*pSTAB                    LM21 *gfp* Δ*kpbC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S22            LM21Δ*kpdC-kana/*pSTAB                    LM21 *gfp* Δ*kpdC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S23            LM21Δ*kpeC*-*kana*/pSTAB                  LM21 *gfp* Δ*kpeC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S24            LM21Δ*kpgC-kana/*pSTAB                    LM21 *gfp* Δ*kpgC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S25            LM21Δ*kpjC-kana/*pSTAB                    LM21 *gfp* Δ*kpjC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S26            LM21Δ*mrkC-kana/*pSTAB                    LM21 *gfp* Δ*mrkC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S27            LM21Δ*fimC-kana/*pSTAB                    LM21 *gfp* Δ*fimC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, Km^r^                                                                                           This study
  S28            LM21Δ*kpaC-kana*-*Strepto*/pSTAB-*kpaC*   LM21 *gfp* Δ*kpaC*::KmFRT/pSTAB\_*kpaC*; Sp^r^, Km^r^,Ap^r^, St^r^                                                                                    This study
  S29            LM21Δ*kpbC-kana*-*Strepto*/pSTAB-*kpbC*   LM21 *gfp* Δ*kpbC*::*KmFRT*/pSTAB\_*kpbC*; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                 This study
  S30            LM21Δ*kpdC-kana*-*Strepto*/pSTAB-*kpdC*   LM21 *gfp* Δ*kpdC*::KmFRT/pSTAB\_*kpdC*; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                   This study
  S31            LM21Δ*kpeC-kana*-*Strepto*/pSTAB-*kpeC*   LM21 *gfp* Δ*kpeC*::*KmFRT*/pSTAB\_*kpeC*; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                 This study
  S32            LM21Δ*kpgC-kana*-*Strepto*/pSTAB-*kpgC*   LM21 *gfp* Δ*kpgC*::*KmFRT*/pSTAB\_*kpgC*; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                 This study
  S33            LM21Δ*kpjC-kana*-*Strepto*/pSTAB-*kpjC*   LM21 *gfp* Δ*kpjC*::*KmFRT*/pSTAB\_*kpjC*; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                 This study
  S34            LM21Δ*mrkC-kana*-*Strepto*/pSTAB-*mrkC*   LM21 *gfp* Δ*mrkC*::*KmFRT*/pSTAB\_*mrkC*; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                 This study
  S35            LM21Δ*fimC-kana*-*Strepto*/pSTAB-*fimC*   LM21 *gfp* Δ*fimC*::*KmFRT*/pSTAB\_*fimC*; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                 This study
  S36            LM21Δ*kpaC-kana*-*Strepto/*pSTAB          LM21 *gfp* Δ*kpaC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S37            LM21Δ*kpbC-kana*-*Strepto/*pSTAB          LM21 *gfp* Δ*kpbC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S38            LM21Δ*kpdC-kana*-*Strepto/*pSTAB          LM21 *gfp* Δ*kpdC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S39            LM21Δ*kpeC-kana*-*Strepto*/pSTAB          LM21 *gfp* Δ*kpeC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S40            LM21Δ*kpgC-kana*-*Strepto/*pSTAB          LM21 *gfp* Δ*kpgC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S41            LM21Δ*kpjC-kana*-*Strepto/*pSTAB          LM21 *gfp* Δ*kpj*C::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S42            LM21Δ*mrkC-kana*-*Strepto/*pSTAB          LM21 *gfp* Δ*mrkC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S43            LM21Δ*fimC-kana*-*Strepto/*pSTAB          LM21 *gfp* Δ*fimC*::KmFRT/pSTAB; Sp^r^, Km^r^, Ap^r^, St^r^                                                                                           This study
  S44            LM21Δ*kpaC*                               LM21 *gfp* Δ*kpaC*; Sp^r^                                                                                                                             This study
  S45            LM21Δ*kpbC*                               LM21 *gfp* Δ*kpbC*; Sp^r^                                                                                                                             This study
  S46            LM21Δ*kpdC*                               LM21 *gfp* Δ*kpdC;* Sp^r^                                                                                                                             This study
  S47            LM21Δ*kpe*C                               LM21 *gfp* Δ*kpeC*, Sp^r^                                                                                                                             This study
  S48            LM21Δ*kpgC*                               LM21 *gfp* Δ*kpgC;* Sp^r^                                                                                                                             This study
  S49            LM21Δ*kpjC*                               LM21 *gfp* Δ*kpj*C; Sp^r^                                                                                                                             This study
  S50            LM21Δ*mrkC*                               LM21 *gfp* Δ*mrkC;* Sp^r^                                                                                                                             This study
  S51            LM21Δ*fimC*                               LM21 *gfp* Δ*fimC*, Sp^r^                                                                                                                             This study
  S52            LM21Δ*kpaC*/pSTAB-*kpaC*                  LM21 *gfp* Δ*kpaC*/pSTAB\_*kpaC*; Sp^r^, Ap^r^                                                                                                        This study
  S53            LM21Δ*kpbC*/pSTAB-*kpbC*                  LM21 *gfp* Δ*kpbC*/pSTAB\_*kpbC*; Sp^r^, Ap^r^                                                                                                        This study
  S54            LM21Δ*kpdC*/pSTAB-*kpdC*                  LM21 *gfp* Δ*kpd*C/pSTAB\_*kpdC*; Sp^r^, Ap^r^                                                                                                        This study
  S55            LM21Δ*kpeC*/pSTAB-*kpeC*                  LM21 *gfp* Δ*kpeC*/pSTAB\_*kpeC*; Sp^r^, Ap^r^                                                                                                        This study
  S56            LM21Δ*kpgC*/pSTAB-*kpgC*                  LM21 *gfp* Δ*kpgC*/pSTAB\_*kpgC*; Sp^r^, Ap^r^                                                                                                        This study
  S57            LM21Δ*kpjC*/pSTAB-*kpjC*                  LM21 *gfp* Δ*kpjC*/pSTAB\_*kpjC*; Sp^r^, Ap^r^                                                                                                        This study
  S58            LM21Δ*mrkC*/pSTAB-*mrkC*                  LM21 *gfp* Δ*mrkC*/pSTAB\_*mrkC*; Sp^r^, Ap^r^                                                                                                        This study
  S59            LM21Δ*fimC*/pSTAB-*fimC*                  LM21 *gfp* Δ*fimC*/pSTAB\_*fimC*; Sp^r^, Ap^r^                                                                                                        This study
  S60            LM21Δ*kpaC/*pSTAB                         LM21 *gfp* Δ*kpaC*/pSTAB; Sp^r^, Ap^r^                                                                                                                This study
  S61            LM21Δ*kpbC/*pSTAB                         LM21 *gfp* Δ*kpbC*/pSTAB; Sp^r^, Ap^r^                                                                                                                This study
  S62            LM21Δ*kpdC/*pSTAB                         LM21 *gfp* Δ*kpdC*/pSTAB; Sp^r^, Ap^r^                                                                                                                This study
  S63            LM21Δ*kpeC/*pSTAB                         LM21 *gfp* Δ*kpeC*/pSTAB; Sp^r^, Ap^r^                                                                                                                This study
  S64            LM21Δ*kpgC/*pSTAB                         LM21 *gfp* Δ*kpgC*/pSTAB; Sp^r^, Ap^r^                                                                                                                This study
  S65            LM21Δ*kpjC/*pSTAB                         LM21 *gfp* Δ*kp*C/pSTAB; Sp^r^, Ap^r^                                                                                                                 This study
  S66            LM21Δ*mrkC*/pSTAB                         LM21 *gfp* Δ*mrkC*/pSTAB; Sp^r^, Ap^r^                                                                                                                This study
  S67            LM21Δ*fimC/*pSTAB                         LM21 *gfp* Δ*fimC*/pSTAB; Sp^r^, Ap^r^                                                                                                                This study
  S68            TOP10                                     *E*.*coli* from invitrogen                                                                                                                            Invitrogen
  **Plasmids**   ** **                                                                                                                                                                                           
  V1             pKOBEG199                                 Plasmid encoding Lambda Red recombinase protein                                                                                                       \[[@pone.0116215.ref031]\]
  V2             pKD4                                      Plasmid with FRT-flanked kanamycin-resistance cassette used for kanamycin casette amplification, Km^r^, Ap^r^, Km^r^,                                 \[[@pone.0116215.ref033]\]
  V3             pBlunt                                    Used for PCR product cloning                                                                                                                          Invitrogen
  V4             pSTAB                                     pZE derivative plamsid. Contains the *flm* toxin-antitoxin system from F plasmid; Ap^r^                                                               Gift from J.M. Ghigo
  V5             pCP20                                     pCP20 carries the yeast recombinase gene (FLP, aka exo), chloramphenicol and ampicillin resistant gene and temperature sensitive replication. Ap^r^   \[[@pone.0116215.ref032]\]

Abbreviations: Ap, ampicillin; Km, kanamycin; St, streptomycin; Sp, spectinomycin

Cloning of the *K*. *pneumoniae* LM21 usher-like genes, construction of isogenic and transcomplementation mutants {#sec007}
-----------------------------------------------------------------------------------------------------------------

Primers were designed on the basis of *K*. *pneumoniae* LM21 genome sequence information. All primers used are listed in [Table 1](#pone.0116215.t001){ref-type="table"}. Chromosomal DNA extraction was performed by NucleoSpin tissue kit (Macherey-Nagel) according to the manufacturer's recommendations.

The usher-defective mutants were created by allelic exchange after replacement of the Usher encoding gene by the selectable kanamycin resistance gene according to Chaveroche et *al*. \[[@pone.0116215.ref031]\]. The kanamycin cassette flanked by 60-bp fragments, which correspond to the encoding upstream and downstream regions of the usher encoding gene, was generated using pKD4 plasmid as template and primers P17 to P32 ([Table 1](#pone.0116215.t001){ref-type="table"}). They were electroporated in the *K*. *pneumoniae* LM21 strain harboring the lambda-red protein-encoding plasmid pKOBEG199 under the control of a promoter induced by [l]{.smallcaps}-arabinose. Mutants were selected onto LB agar containing kanamycin. The loss of the pKOBEG199 plasmid was then checked on LB containing tetracycline. The substitution of the encoding usher gene by the kanamycin cassette was further checked by PCR performed with primers P33 and P34 ([Table 1](#pone.0116215.t001){ref-type="table"}). In a second step, the antibiotic resistant encoding gene was excised from the mutant's genome using the pCP20 plasmid, a temperature-sensitive replication plasmid with thermal induction of flippase recombinase (FLP) synthesis \[[@pone.0116215.ref032]\], which gave rise to nonpolar mutants as previously described in Datsenko et *al*. \[[@pone.0116215.ref033]\]. For *in vivo* assays, spontaneous mutants of Δ*usher-kana* (designated LM21Δ*usher*-*kana* in [Table 2](#pone.0116215.t002){ref-type="table"}) were selected for streptomycin resistance (designated LM21Δ*usher*-*kana-strepto* in [Table 2](#pone.0116215.t002){ref-type="table"})

PCRs were performed using a Biorad T100 Thermal cycler. Restriction enzymes, Phusion high-Fidelity DNA polymerase and TaKaRa LA Taq were purchased from New England Biolabs, Thermo Scientific and Takara Biotechnology Inc, respectively, and used according to the manufacturers' recommendations.

For transcomplementation assays, fragments containing the entire *usher-like* genes and their own putative promoters, as detected by sequence analysis, were amplified from *K*. *pneumoniae* LM21 genomic DNA by an overlapping extension PCR using primers listed in [Table 1](#pone.0116215.t001){ref-type="table"} (P35 to P66). The resulting fragment was cloned using Zero Blunt PCR cloning kit (Invitrogen) and subcloned into the *Eco*R1 or *Bam*H1 digested pSTAB vector. Resulting recombinant vectors (pSTAB-*usher*) were then introduced by electroporation into the isogenic mutants. In parallel, the LM21 wild type strain and the isogenic mutants were transformed with the empty pSTAB plasmid vector ([Table 2](#pone.0116215.t002){ref-type="table"}).

RNA manipulations, real-time RT-PCR {#sec008}
-----------------------------------

Total RNA was extracted from bacteria grown in 3 different media conditions (LB, M63B1 and DMEM), using Trizol reagent (Invitrogen) according to the method described by Toledo-Araba et *al*. \[[@pone.0116215.ref034]\] after lysing bacteria in the Precellys tissue homogenizer (Bertin Technologie). Reverse transcription was performed with the iScript cDNA synthesis kit (Biorad) using 1 μg of RNA on the T100 Thermal Cycler (Biorad) according to the manufacturers' recommendations, and quantification of cDNA levels was done using the SsoAdvanced Universal SYBR Green Supermix (Biorad) on a C1000 thermal Cycler- CFX96 (Biorad) with primers P67 to P82 ([Table 1](#pone.0116215.t001){ref-type="table"}). As internal controls, the *rpoB* gene was amplified with primers P83/P84. Amplification of a single expected product was confirmed by melting curve analysis. The amplification efficiency (E) of the reactions for the target genes was determined and used to compare relative gene expression. The ratio = (E~sample~)^ΔCPsample^ / (E~reference~)^ΔCPreference^ was calculated (CP: crossing point).

Biofilm assays {#sec009}
--------------

The ability of bacteria to form biofilm was assessed in both a static microtiter plate and a dynamic microfermentor biofilm model. All experiments were performed in biological and technical triplicates. For the microtiter experiment measuring the early biofilm formation capacity, 4.10^6^ CFU/mL of an overnight culture were inoculated into 100μl of M63B1--0.4% Glu in a 96-well PVC microtiter plate (Falcon). After 4h incubation at 37°C, bacterial cells were stained for 15 minutes at room temperature by adding 50 μl of 0.5% (wt/vol) aqueous solution of crystal violet in each well. After five washes with distilled water, the bound dye was released from stained cells using 95% ethanol and measured by absorbance at 570 nm.

Biofilm formation was performed in 60 ml aerated microfermentors to assess mature biofilm formation as described by Ghigo et *al*. \[[@pone.0116215.ref035]\]. Continuous flow of 100ml/h of M63B1--0.4% Glu medium and constant aeration with sterile pressed air (0.3 bar) were used. After 24h of incubation, mature biofilms formed on the removable glass slide were dislodged by vortexing and sonication and resuspended in saline. Bacterial biomass was quantified by determining the number of CFUs.

Cell line growth and adhesion assays {#sec010}
------------------------------------

Intestine 407 (Int-407) cells derived from human embryonic intestinal epithelium were purchased from American Type Culture Collection (ATCC strain CCL-6). Cells were grown in a humidified incubator at 37°C under 5% CO~2~. Cells were cultured in Dulbecco's Modifed Eagle Medium (DMEM) (PAA-laboratories GmbH---Dominique Dutscher) containing 10% (v/v) heat-inactivated fetal bovine serum (PAA-laboratories GmbH---Dominique Dutscher), 50 U/mL penicillin, and 50 μg/mL streptomycin. Adhesion assays were conducted in biological and technical triplicate over three to five successive passages of Int-407 cells. Briefly, monolayers were seeded with 4 × 10^5^ cells per well in 24-well tissue culture plates (Polylabo, Strasbourg, France) and incubated for 24 h. Monolayers were then infected at a multiplicity of infection (MOI) of 100 bacteria per cell in 1 ml of the cell culture medium without antibiotics and with heat-inactivated fetal calf serum (FCS) (PAA-laboratories GmbH---Dominique Dutscher). After incubation for 4h at 37°C in an atmosphere of 5% CO~2~, unattached bacteria were removed by washing the cell monolayers four times with sterile PBS. After detachment of the cells by addition of 1mL of Triton 1% (in PBS) per well, the suspension was transferred into a 1.5 mL reaction tube and the number of adhering bacteria was determined by quantification of CFUs by plating dilution onto LB agar plates.

*In vitro* plant adhesion assays {#sec011}
--------------------------------

Seeds of wild type *Arabidopsis thaliana* (Col-O) were obtained from the Nottingham *Arabidopsis* Stock Center (NASC). For *in vitro* cultures, seeds were sterilized in 70% EtOH with 0.05% SDS followed by washing in 95% EtOH, dried and sown on germination medium containing 0.8% w/v agar, 1% w/v sucrose and half-strength Murashige & Skoog salts (M0255; Duchefa Biochemie, Netherlands). After 2 days of stratification at 4°C in darkness, plants were grown under long-day conditions (6h light/8h dark cycles) at 23°C. Fifteen-day-old *Arabidopsis* plants were used for the *in vitro* adhesion assays.

Bacterial adhesion was tested as described in Haahtela *et al*. \[[@pone.0116215.ref036]\]. Briefly, 2.5 x 10^6^ bacteria were incubated with whole plants in 5 ml of PBS at room temperature in a controlled environment incubator shaker set at 30 rpm for 4 hours. A non-infected plant control was maintained under the same conditions. The plants were then washed twice for 15 min with 10mL of saline (0.9 \[w/s\] sodium chloride) and homogenized in 1mL of saline with a tissue grinder (Kontes, size C), and the suspension was serially diluted and the number of adhering bacteria was determined by quantification of CFUs by plating the dilution onto LB agar plates. Each experiment was conducted in biological and technical triplicate.

Mice Intestinal colonisation {#sec012}
----------------------------

Female specific-pathogen mice (OF1 Swiss; 3 to 5 weeks old, 22g, Charles River Swiss) were used. The models and protocols used in this study were all approved by the ethics committee of Auvergne (Comité Régional d\'Ethique en Matière d\'Expérimentation Animale Auvergne, CEMEEA C2EA-02) in compliance with the European Community guiding in the care and use of laboratory animals (86/609/CEE). A total of 50 animals were used in this experiment. Animals were housed five to a cage in a temperature-controlled room with a 12 h light/12 h dark cycle and were fed with Rodent Diet (A04-Safe, Epinay/Orge, France) ad libitum throughout the experiments. Cages were cleaned each two days. One day prior to infection, water was withdrawn and replaced with sterile water containing 5g of streptomycin per liter throughout the experiment. After 1 week of acclimation, 200 μl of bacterial suspension in sterile water (10^7^ CFU) were given intragastrically to each mouse. For competition assays, each of the 8 LM21Δ*usher*-*kana-strepto* mutants was mixed with wild type strain LM21 in equal amounts in 200μl sterile water and administered intragastrically to 5 mice per group. The mutant strains showing a deficiency in colonization were then tested individually (5 mice per strain) and in competition with their respective trans-complemented strain by the same procedure. After 1 day and subsequently every day for 10 days, feces were collected and homogenized in 1mL saline, and serial dilutions were plated onto selective media. As described above, the removed feces were plated onto streptomycin-containing LB plates to measure the total number of CFUs and onto streptomycin-kanamycin-containing LB plates to measure the number of Δ*usher* mutant CFUs. From these numbers, the exact ratio of mutant to wild type or transcomplement was calculated for inoculum and feces contents. Mice were euthanized by cervical dislocation on day 12. Each experiment was conducted in biological and technical triplicate.

Western blot analysis of type 3 fimbriae expression {#sec013}
---------------------------------------------------

Overnight grown bacteria (8.10^9^) were mechanically disrupted by sonication in 2mL of 40mM Tris-buffer, and lysates were centrifuged for 10 min at 20,000 g to pellet unbroken cells. Supernatants were ultracentrifuged for 1h at 100,000g, and pellets suspended in 0.1 mL of sarkosyl 0.5% were then incubated for 30 min on ice to solubilize inner membrane. Samples were then ultracentrifuged 1h at 100,000g, and pellets were suspended in 0.05 mL of tris-buffer. Protein quantification was performed using Bradford Protein Assay (Biorad) reagent according the manufacturers' recommendations. Five μg of protein samples were then analyzed by western blotting using an anti-MrkA polyclonal antibody (generous gift from Steven Clegg).

Statistical analysis {#sec014}
--------------------

For analysis of the significance of differences, Student's t-test was used to compare data from the two groups. All experiments were made at least three times. A P-value of ≤ 0.05 was considered to be statistically significant. RT-PCR statistical analysis was performed using the non-parametric One-way ANOVA. P values of ≤ 0.05 were considered to be statistically significant.

Accession Numbers {#sec015}
-----------------

The INSDC accession numbers of usher proteins used in this study are listed below. *Klebsiella pneumoniae* HS11286 (AEW59011, AEW59085, AEW60001, AEW61304, AEW6304); *Klebsiella pneumoniae* MGH 78578 (ABR75716, ABR75717, ABR75730, ABR75944, ABR77102, ABR78394,ABR78675, ABR78797, ABR79828, ABR79894); *Klebsiella pneumoniae* NTUH-K2044 (BAH61229, BAH61295,BAH61460, BAH62173, BAH63378, BAH64776, BAH64779, BAH65059, BAH65073); *Klebsiella variicola* 342 (initially identified as *K*. *pneumoniae*: ACI08730, ACI09976, ACI10676, ACI09288, ACI10013, ACI08659, ACI06599, ACI08146, ACI08479); *Klebsiella pneumoniae* KCTC 2242 (AEJ96010, AEJ96079, AEJ96970, AEJ98151, AEJ99466, AEJ99752, AEJ99817, AEJ99818, AEJ99901); Klebsiella *pneumoniae* JM45 (AGT22732, AGT22745, AGT23011, AGT24313, AGT25490, AGT25491, AGT26343, AGT26409); *Klebsiella pneumoniae* CG43 (AGX39043, AGX39045, AGX41005, AGX40456); *Klebsiella pneumoniae* 1084 (AFQ64205, AFQ67915, AFQ67856, AFQ67011, AFQ65856, AFQ67240, AFQ64480, AFQ64205); *Klebsiella pneumoniae* Kp13 (AHE42797, AHE42813,AHE43103, AHE43106, AHE44628, AHE45921, AHE46162, AHE46764, AHE46837); *Klebsiella pneumoniae* 30684/NJST258_2 (AHM77757, AHM77758, AHM77775, AHM78064, AHM78067, AHM79571, AHM80854, AHM80923, AHM81143, AHM81806, AHM81807, AHM81882); *Klebsiella pneumoniae* 30660/NJST258_1 (AHM83349, AHM83350, AHM83368, AHM83664, AHM83667, AHM85224, AHM86458, AHM86526, AHM86817, AHM87489, AHM87490, AHM87517); *Klebsiella pneumoniae* [LM21 (KPLM21_90123, KPLM21_160040, KPLM21_610081, KPLM21_1040039, KPLM21_200008, KPLM21 \_1000123, KPLM21_90135, KPLM21_220012).]{.smallcaps}

Results {#sec016}
=======

Identification and characterization of CU fimbrial loci in *K*. *pneumoniae* LM21 genome {#sec017}
----------------------------------------------------------------------------------------

In the *K*. *pneumoniae* LM21 genome, a total of eight potential CU fimbrial operons defined as polycistronic gene clusters containing at least one usher and one chaperone encoding sequence and flanked by one or more genes encoding fimbrial subunits were identified. The genetic organization of these CU fimbrial gene clusters ([Fig. 1](#pone.0116215.g001){ref-type="fig"}) was predicted by inspecting individual genes for conserved fimbrial protein domains. The usher proteins are members of a classical chaperone/usher family and share conserved domains (PFAM00577 and/or COG3188). The presence of usher encoding genes was confirmed by PCR using primers P1 to P16 ([Table 1](#pone.0116215.t001){ref-type="table"}). The LM21 *K*. *pneumoniae* CU loci comprised type 1 and type 3 fimbrial gene clusters *fim* and *mrk* that are divergently clustered and transcribed. Five of the other six LM21 CU loci showed a strong similarity toward operons found out by Wu *et al*. \[[@pone.0116215.ref018]\] in strain NTUH-K2044. Together with type 1 and type 3, they showed a minimum of 93% of identity (coverage length \>98%) when compared to NTUH-K2044 operon subunit, with an identity value between 95 and 100% for usher encoding genes. The common CU operons between LM21 and NTUH-K2044 strains were *kpa*, *kpb*, *kpd*, *kpe*, *kpg*, *mrk* and *fim* accordingly to the nomenclature proposed by Wu *et al*. \[[@pone.0116215.ref037]\].~.~ The eighth LM21 CU operon detected, which corresponds to ORFs KPLM21_200008.KPLM21_200011, has not been described so far; as *kph* and *kpi* were proposed recently for novel CU clusters in *K*. *pneumoniae* strains BJ1-GA and SA1 \[[@pone.0116215.ref038]\], the novel cluster from LM21 was called *kpj*. Using these data as well as the sequences of the CU fimbriae usher detected in the twelve NCBI sequenced *K*. *pneumoniae* genomes (S1), which contain an average of 9 CU operons/genome (minimum 5 and maximum 12), a circular phylogram was constructed to display the evolutionary relationship of these amino acid sequences (See [S1 Table](#pone.0116215.s001){ref-type="supplementary-material"}). The circular phylogram of *K*. *pneumoniae* usher sequences demonstrated that the *K*. *pneumoniae* species contains representatives of the six clades defined by Nuccio & Baumler \[[@pone.0116215.ref003]\] ([Fig. 2](#pone.0116215.g002){ref-type="fig"}). The γ clade was the largest and encompassed 50 CU fimbrial types across five subclades.

![Genetic organization of CU fimbrial types identified in *Klebsiella pneumoniae* LM21.\
The genetic organization of the different fimbrial types is depicted diagrammatically. The designation of putative fimbrial genes and the locus tag of ORFs annotated in the *K*. *pneumoniae* LM21 genome are indicated. A total of eight fimbrial gene clusters and genes encoding putative regulators are shown. Each of these fimbrial loci is underlined. Fimbriae are grouped according to the Nuccio cladding scheme (Nuccio and Baümler, 2007). Genes are color-coded according to predicted function of the corresponding protein product, with associated Pfam and COG domains indicated (CGO and PF). The scale represents DNA length in kilo base pair. Reference locus tags for individual fimbrial types are displayed under the locus.](pone.0116215.g001){#pone.0116215.g001}

![Circular phylogram of fimbrial usher proteins identified in *K*. *pneumoniae*.\
A total of 90 amino acid sequences deduced from the 7 to 9 CU loci of the twelve *K*. *pneumoniae* genomes available in the NCBI data bank were used to infer the evolutionary relationship of usher protein. Fimbrial gene clusters were grouped according to the Nuccio subclade system (α, β, ϭ, п, κ, γ) and highlighted in color. *K pneumoniae* LM21 usher proteins are leaf labeled in red.](pone.0116215.g002){#pone.0116215.g002}

The classification of the fimbrial gene clusters into CU clades based on the usher sequences was previously shown to correlate with the gene arrangement within clusters \[[@pone.0116215.ref039]\]. The eight LM21 usher loci belong to γκп (for seven of them) and ϭ clade (one of them, LM21*kpd*) ([Fig. 1](#pone.0116215.g001){ref-type="fig"}) and are characterized by a common pilus subunit homology domain (PFAM00419). Seven CU loci share the same gene organization encoding first the major subunit then a chaperone followed by an usher (MCU organization: M for major subunit, C for chaperone and U for usher) ([Fig. 1](#pone.0116215.g001){ref-type="fig"}). They are split into different subclades: LM21*kpa*, LM21*kpe*, LM21*kpg*, LM21*kpj and* LM21*fim* are MCUT (T for Tip adhesin)-organized and belong to γ1 subclade. They share, like all γ clade members, the PFAM00419 subunit domain and a COG3539 domain, which are also found in subunits of γ1 and γ2 fimbriae. The LM21*mrk* operon, which is MCUT-organized, belongs to the γ~4~---fimbriae. Unlike other members of the γ-fimbriae, the LM21*kpb* operon belongs to the γ3-fimbriae with a MCUM (M for Major subunit) organization that does not contain the conserved domains PFAM00419 and COG3539 but PFAM04619 subunit domain and PFAM02753 chaperone domain ([Fig. 1](#pone.0116215.g001){ref-type="fig"}). Finally, the LM21*kpd* operon belongs to the ϭ cluster with an MCUT core operon structure and has significant homology to COG5430 domains in its subunits. Chaperones of the LM21*kpd* operon contain either a COG00345 domain only or a COG3121 domain and a PFAM00345 domain. No tip adhesin was present in this locus.

Real time RT-PCR analysis performed using RNA samples from bacteria grown in rich (LB, DMEM) or minimal (M63B1) media used for phenotypical characterization showed that the eight LM21 usher encoding genes were all expressed, whatever the growth conditions. Compared to the *rpoB* housekeeping gene, there was no variation of usher gene expression between the different media, excepted for *kpgC* which was expressed at higher level in DMEM compared to LB (p\<0.05; ANOVA) ([Table 3](#pone.0116215.t003){ref-type="table"}).

10.1371/journal.pone.0116215.t003

###### RT-PCR analysis of usher genes expression in M63B1, LB and DMEM media.

![](pone.0116215.t003){#pone.0116215.t003g}

               Culture medium                  
  ------------ ---------------- -------------- --------------
  ***kpaC***   46.6 ± 10.7      51.6 ± 8.2     49.6 ± 21.1
  ***kpbC***   7.1 ± 1.2        7.5 ± 0.8      7.1 ± 0.4
  ***kpdC***   52.0 ± 2.2       40.9 ± 3.2     55.1 ± 11.0
  ***kpeC***   441.3 ± 81.7     382.4 ± 83.1   344.4 ± 58.5
  ***kpgC***   93.6 ± 4.2       111.6 ± 20.4   75.3 ± 8.5
  ***kpjC***   94.6 ± 9.9       81.4 ± 20.3    92.6 ± 5.7
  ***mrkC***   16.6 ± 0.6       17.2 ± 2.9     14.7 ± 1.5
  ***fimC***   30.5 ± 1.4       34.1 ± 1.5     28.2 ± 4.9

Results were expressed in fold-decreased expression (±SD) compared to *rpoB* housekeeping gene expression level. Expression levels were compared by nonparametric one-way ANOVA, comparing expression of each usher gene in the three different media. Only *kpgC* expression was higher in DMEM compared to LB; p \< 0.05 (ANOVA).

To investigate the role of the LM21 *K*. *pneumoniae* CU loci, isogenic deletion mutants were created by allelic replacement of each of the eight potential encoding usher genes. The growth rate of each mutant was similar to that of the wild type ([S1 Fig.](#pone.0116215.s003){ref-type="supplementary-material"}). Western blot analysis performed with MrkA specific antibodies showed that all usher deleted mutants, except Δ*mrkC*, expressed type 3 pili at their cell surface ([S2 Fig.](#pone.0116215.s004){ref-type="supplementary-material"}). In addition, assessment of the expression of the 7 usher genes in Δ*mrkC* mutant by RT-PCR indicated that there was no significant variation compared to the wild-type strain ([S2 Table](#pone.0116215.s002){ref-type="supplementary-material"}).

Adhesion and colonization phenotype of usher deletion mutants {#sec018}
-------------------------------------------------------------

Determination of biofilm biomass using CV staining in microtiter plates and biomass determination in the microfermentor device indicated that three mutants (LM21Δ*kpaC*, LM21Δ*kpgC* and LM21Δ*mrkC*) were impaired in their biofilm formation ability compared to the wild type *K*. *pneumoniae* LM21 strain ([Fig. 3](#pone.0116215.g003){ref-type="fig"}). The ability to form biofilm was partially restored by transcomplementation with the wild type usher encoding gene (up to 80% of the wild type level), whatever the biofilm formation model used ([Fig. 3A and 3B](#pone.0116215.g003){ref-type="fig"}).

![Biofilm formation capacity of the *K*. *pneumoniae* LM21*Δusher* mutants strains and, for three of them, their transcomplemented strains.\
Biofilms developed were quantified (A) by crystal violet staining on microtiter plates after 4 hours of incubation and (B) by CFU determination after 24 hours of incubation in the microfermentor model, as described in experimental procedures. Data are means of measurement made in triplicate. The biofilm formation ability of the mutant strains is expressed as a percentage of LM21 wild type biofilm, set to 100% (OD~600~ and CFU values for the *K*. *pneumoniae* LM21 wild type are respectively 0.52 and 1.24x10^9^). The error bars represent standard errors of the means. Significant differences are indicated by \* and \*\* for p \< 0.05 and p\<0.01, respectively (Student's t-test).](pone.0116215.g003){#pone.0116215.g003}

The eight usher-deleted mutants were also tested for their ability to adhere to human intestinal Int-407 cells. Two of the mutants (LM21Δ*kpgC* and LM21Δ*mrkC*) adhered less than the wild type strain LM21, (75% and 20%, respectively) whereas the six other mutants did not show any difference compared to the parental strain. The adhesion phenotype was partially restored by the trans-complemented strains (up to 80% of the wild type level) ([Fig. 4](#pone.0116215.g004){ref-type="fig"}).

![Adhesion assays to Int-407 cells of the LM21*Δusher* mutants strains and, ² for two of them, their transcomplemented mutants.\
Results are expressed as the percentages of LM21 wild type adhesion, set to 100% (CFU value for *K*. *pneumoniae* LM21 wild type was 1.93x10^9^). Data are the means of measurements made in biological and technical triplicate. Significant differences are indicated by \* p \< 0.05 and \*\* for p\<0.01 (Student's t-test).](pone.0116215.g004){#pone.0116215.g004}

Adhesion assays performed with whole 15-day-old *A*. *thaliana* specimens showed that four mutants, LM21Δ*kpeC*, LM21Δ*kpjC*, LM21Δ*fimC* and LM21Δ*mrkC*, adhered at significantly lower levels than those of the wild type strain (P\<0.01 with LM21Δ*kpjC* and P\<0.05 for LM21Δ*kpeC*, LM21Δ*fimC)* ([Fig. 5](#pone.0116215.g005){ref-type="fig"}).

![Adhesion assays to *Arabidopsis thaliana* whole seedlings of the *K*. *pneumoniae* LM21*Δusher* mutants strains and, for four of them, their transcomplemented mutants.\
Results are expressed as the percentages of LM21 wild type adhesion, set to 100% (CFU value for *K*. *pneumoniae* LM21 wild type was 1.47.10^7^). Data are the means of measurements made in biological and technical triplicate. Significant differences are indicated by \* and \*\* for p \< 0.05 and p\<0.01 respectively (Student's t-test).](pone.0116215.g005){#pone.0116215.g005}

Determination of the ability of each usher mutant to colonize mice intestinal tract concurrently with the parental wild type strain indicated that four mutants, LM21Δ*kpgC*, LM21Δ*kpjC*, LM21Δ*fimC* and LM21Δ*mrkC*, were significantly impaired compared to the levels of the wild type strain ([Fig. 6A](#pone.0116215.g006){ref-type="fig"}) (P\<0.01 by the student's test for LM21Δ*kpgC and* LM21*mrkC* P\<0.05 for *fimC* and P\<0.01 for LM21Δ*kpjC*). Further colonization assays performed with the highest attenuated mutant, LM21Δ*kpjC*, showed that this mutant alone was also unable to colonize the intestinal tract and was outcompeted by its trans-complemented LM21Δ*kpjC/*pSTAB-*kpjC* mutant ([Fig. 6B](#pone.0116215.g006){ref-type="fig"}).

![Colonization assays in the murine model of *K. pneumoniae* LM21*Δusher* mutants strains and trans-complemented mutants.\
(A) The colonization properties of the strains are shown as the competition between the wild type and the eight isogenic mutants. (B) For mutants showing an highly attenuated phenotype, individual assays involving the mutant alone and in competition assays with its trans-complemented strain were conducted. Data are means of measurement made with 5 mice per group. Significant differences are indicated by \* and \*\* for p \< 0.05 and p\<0.01, respectively (Student's t-test).](pone.0116215.g006){#pone.0116215.g006}

Discussion {#sec019}
==========

To detect CU clusters, the choice of the usher as target gene was conditioned by the fact that one usher encoding gene is ubiquitously associated with all CU gene clusters and is present in a single copy in all CU gene clusters so far described. A total of eight potential usher-encoding genes were detected in *K*. *pneumoniae* LM21 genome, all of them harboring adjacent cognate chaperone-encoding and fimbrial subunit-encoding genes. Whereas genes for CU pathways have been shown to be encoded on both chromosomal and plasmid locations \[[@pone.0116215.ref040],[@pone.0116215.ref041]\], the eight CU loci detected in the genome of *K*. *pneumoniae* LM21 were located on the chromosome and most of them belonged to the γ~1~ subclade. This result highlights the main role of this subclade in bacterial survival and pathogeny processes as previously suggested \[[@pone.0116215.ref041]\]. In addition, analysis of the surrounding regions of each CU operon did not reveal potential mobile DNA sequences (data not shown), suggesting that these operons have not been acquired through recent lateral gene transfers \[[@pone.0116215.ref042]\].

Of the eight CU-loci detected in *K*. *pneumoniae* LM21 genome, two corresponded to previously well-characterized CU operons. The locus with ORFs KPLM21_90133 to KPLM21_90137 was identified as the type 3-encoding *mrk* operon previously described in all members of the family *Enterobacteriaceae*. While first identified and characterized in *Klebsiella*, type 3 pili are commonly found in other *Enterobacteriaceae*, and *mrk* gene clusters are mostly chromosome-borne \[[@pone.0116215.ref007],[@pone.0116215.ref043],[@pone.0116215.ref044]\]. m*rk* operon belongs to γ~4~ clade and shares the core operon structure present in all members of the γ~4~ clade \[[@pone.0116215.ref003]\]. The type 3 fimbriae are characterized by their ability to agglutinate erythrocytes treated with tannic acid *in vitro*, and this phenotype has been referred to as the mannose-resistant *Klebsiella-*like hemagglutination (MR/K) reaction \[[@pone.0116215.ref045]\]. Type 3 fimbriae have also been shown to mediate attachment to endothelial and bladder epithelial cell lines and to play a role in biofilm formation on abiotic surfaces and surfaces coated with host-derived materials \[[@pone.0116215.ref002],[@pone.0116215.ref046]--[@pone.0116215.ref051]\]. Previous studies have also reported that type 3 fimbriae are efficient in promoting enterobacterial adherence to the roots of various grasses and cereals \[[@pone.0116215.ref036]\]. In our study, deletion of the usher-encoding ORF of this locus impaired all tested phenotypes, including murine intestinal colonization contrary to the results obtained after deletion of the whole *mrk* operon by Struve *et al*. \[[@pone.0116215.ref047]\]. It has been previously demonstrated that type 3 fimbriae deletion down-regulates type 1 fimbrial expression \[[@pone.0116215.ref002]\]. In this study, deletion of *mrkC* did not significantly modify the expression of the 7 other usher genes in strain LM21 ([S2 Table](#pone.0116215.s002){ref-type="supplementary-material"}), indicating no cross-regulation. Altogether, these results suggest that LM21 type 3 pili is a major actor in bacterial adherence both *in vitro* and *in vivo* by means of a large array of targets and tissue tropisms.

Type 1 fimbriae-encoding operon was the second previously well-known CU operon detected in our study. These fimbriae are found in virtually all members of the family *Enterobacteriaceae* \[[@pone.0116215.ref012]\]. The genetic organization of the *K*. *pneumoniae fim* operon resembles that of *E*. *coli fim* and contains homologs of all nine *fim* genes described previously \[[@pone.0116215.ref003],[@pone.0116215.ref037]\]. *fimC* gene knock-out experiment in *K*. *pneumoniae* LM21 did not impair its biofilm formation capacity, as previously described for other *K*. *pneumoniae* strains \[[@pone.0116215.ref051]--[@pone.0116215.ref054]\]. However, these results are at variance with those obtained in the closely model *E*. *coli*, in which type 1 fimbriae have been shown to promote biofilm formation \[[@pone.0116215.ref053]\]. This intriguing difference could be related to the characteristic production of copious amounts of capsular material by *K*. *pneumoniae* that impedes type 1 functionality during biofilm formation due to the shortness of these pili \[[@pone.0116215.ref055],[@pone.0116215.ref056]\].

In agreement with van Aarsten et *al*.,\[[@pone.0116215.ref057]\], we observed no significant difference between the LM21Δ*fimC* mutant and its parental strains in the *in vitro* animal cell adhesion assay. However, this mutant was impaired in its ability to adhere to *Arabidopsis* seedlings ([Fig. 5](#pone.0116215.g005){ref-type="fig"}), suggesting that the type 1 fimbriae are involved in *K*. *pneumoniae* plant adhesion, as in the grass model of Haahtela *et al*. \[[@pone.0116215.ref036]\]. In addition, and in contrast with previous reports \[[@pone.0116215.ref054],[@pone.0116215.ref057]\], murine intestinal co-colonization assay performed with LM21Δ*fimC* mutant showed that the mutant had a lower colonization capacity than the wild type.

In addition to type 3 and type 1-encoding operons, *K*. *pneumoniae* LM21 genome harbored six other CU fimbriae systems. The newly identified *kpj* cluster was shown to be involved in adhesion to *Arabidopsis* tissues and in murine colonization. Determination of the ability of each mutant to colonize the murine intestinal tract was initially performed in co-colonization assays including the wild-type strain. To avoid misinterpretation due to concurrent colonization processes that potentially influence the host immune status and thus modify the capacity of both microorganisms to establish, the LM21Δ *kpj* mutant was assessed individually in the murine model; the bacterial load in the animals feces rapidly declined, indicating the mutant was also impaired in its colonization capacity when given alone ([Fig. 6B](#pone.0116215.g006){ref-type="fig"}). Interestingly, the LM21Δ*kpjC* mutant was not impaired in its capacity to adhere to Int-407 cells, suggesting the adhesin potentially encoded by this operon does not recognize receptors at the surface of intestinal cells but rather interacts with other gastro-intestinal components.

Deletion of the LM21*kpjC* usher-encoding gene significantly decreased its ability to form biofilm and its ability to adhere *in vitro* to Int-407 and plant cells, whereas deletion of LM21*kpaC* usher gene was only associated with a decreased ability to form biofilm in both early and late stages. These results suggest that the different fimbrial adhesins harbored by *K*. *pneumoniae* have specific role allowing the bacteria to adhere to different receptors present in different niche and environnement. It has previously been demonstrated that type 1 fimbrial expression is up-regulated in wild type *K*. *pneumoniae* infecting the bladder, but is down-regulated in cells colonizing the intestinal tract or infecting the lungs \[[@pone.0116215.ref054]\].

Regarding the loci LM21*kpb*, LM21*kpd* and LM21*kpe*, no clear *in vitro* or *in vivo* role was identified whatever the phenotype investigated, except for LM21*kpe*, for which deletion induced a slightly decreased adhesion in the plant model. We demonstrated in this study that the 8 LM21 CU usher genes were expressed *in vitro* even though specific demonstration of the presence of corresponding fimbriae at the bacterial cell surface still requires further investigations. Numerous cryptic fimbrial operons have been detected in the genomes of *E*. *coli* K-12, *E*. *coli* O157:H7 and *Salmonella*, whose expression is subject to phase variation in response to environment cues \[[@pone.0116215.ref058]--[@pone.0116215.ref060]\]. Each bacterium likely expresses a few pili type at a given time according to its growth or virulence requirements. Besides, by analogy with other CU systems, the upregulation of expression and biosynthesis of fimbriae could involve a complex interplay of multiple transcriptional regulator, invertible promoter switchs or DNA methylation-based systems, in addition to a potential regulation by the levels of expression of other surface components \[[@pone.0116215.ref005],[@pone.0116215.ref061]--[@pone.0116215.ref063]\].

In conclusion, we report the characterization of eight CU loci on the genome of *K*. *pneumoniae* LM21. Using several *in vitro* and *in vivo* experimental models, we were able to show the involvement of five of them in bacterial adhesion or colonization processes, demonstrating therefore the large adhesion capacity of this species. However, complete demonstration of its adhesion capacities still requires the identification of the substrates recognized by the potential adhesins harbored by the non-yet phenotypically characterized CU operons. In addition, epidemiological studies assessing the presence and the expression of these loci in a large panel of *K*. *pneumoniae* isolates from different sources will complete the elucidation of their respective role.
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======================

###### Strains labels and accession numbers of gene encoding usher identified in *Klebsiella pneumoniae* strains genomes present in NCBI and in this study.

(PDF)

###### 

Click here for additional data file.

###### RT-PCR analysis of the expression of usher genes in the *mrkC*-deleted mutant (type-3 pili usher) and the LM21 wild-type strain.

(PDF)

###### 

Click here for additional data file.

###### Growth curves of LM21 wild-type strain and its usher-deleted mutants.

Bacterial cells were collected every 30 min for 8.5 hours and plated on media. Results are expressed as the number of CFU/ml.

(TIF)

###### 

Click here for additional data file.

###### Western blot of bacterial surface extracts of the usher-deleted mutants and the LM21 wild-type strain.

The figure shows an immunoblot of a gel on which 5 μg of extract from each bacterial strain has been loaded. The gel was immunostained with an antibody that recognizes the major subunit of type 3 pili (MrkA). MW, molecular weight size marker.

(TIF)

###### 

Click here for additional data file.
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